Cargando…
Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention
Despite a vaccine being available, human papillomavirus virus (HPV)-driven cancers remain the ninth most prevalent cancers globally. Current therapies have significant drawbacks and often still lead to poor prognosis and underwhelming survival rates. With gene therapy becoming more available in the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098605/ https://www.ncbi.nlm.nih.gov/pubmed/35380358 http://dx.doi.org/10.1007/s40291-022-00583-5 |